SCHEDULE: FMR LLC Reports 8.1% Stake in Doximity Class A Stock
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson have reported a beneficial ownership of 8.1% of Doximity Inc.'s Class A Common Stock, totaling 11,096,000.02 shares.
Summary
- FMR LLC and Abigail P. Johnson jointly reported beneficial ownership of Doximity Inc. Class A Common Stock.
- The aggregate amount beneficially owned is 11,096,000.02 shares.
- This represents 8.1% of the total outstanding Class A Common Stock.
- FMR LLC holds sole voting power over 11,085,783.45 shares and sole dispositive power over 11,096,000.02 shares.
- Abigail P. Johnson holds sole dispositive power over 11,096,000.02 shares.
- The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Doximity Inc.
- This filing is Amendment No. 3 to the Schedule 13G.
Sentiment
Score: 5
Explanation: This filing is a routine disclosure of beneficial ownership and does not contain information that would inherently indicate a positive or negative sentiment regarding the company's operational performance or future prospects.
Positives
- NA
Negatives
- NA
Risks
- The securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.
Future Outlook
NA
Industry Context
Doximity Inc. operates in the healthcare technology sector, providing a digital platform for medical professionals. FMR LLC's significant stake indicates institutional interest in this growing market segment.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Reporting Entity Structure Disclosure | Abigail P. Johnson is a Director, Chairman, and Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners of Series B voting common shares of FMR LLC, representing 49% of the voting power. A shareholders' voting agreement ensures all Series B voting common shares are voted in accordance with the majority vote of Series B shares. This describes the internal governance of FMR LLC as it relates to its control over the reported shares, not Doximity Inc.'s corporate governance. | NA | Provides transparency on the control structure of the reporting entity (FMR LLC) and its affiliates. |
Related Party Transactions
- The filing details the relationship between FMR LLC and Abigail P. Johnson, who is a Director, Chairman, and CEO of FMR LLC, and the Johnson family's predominant ownership of FMR LLC. This describes the internal control structure of the reporting entity and its affiliates, not a transaction between Doximity Inc. and a related party.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional shareholder's stake, which can influence market perception and liquidity.
- Management: Awareness of a large, passive institutional holder.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement |
| 08/05/2025 | Filing date of this Schedule 13G Amendment No. 3 |
Keywords
Doximity, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Class A Common Stock, Healthcare Technology, Digital Health, Professional Network
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.